Abstract: An ophthalmic surgical apparatus includes: a support provided with an electrical path, and a probe including a conductive material, the probe including a first section coupled to the support and a second section formed integrally with and connected to the first section, the entire surface of the second section being exposed to the outside of the support.

Abstract: A backlight unit is described. The unit includes a light emitting array having a plurality of light sources configured to emit light, and a printed circuit board on which the light sources are arranged; a light guide film configured to guide light emitted from the light sources in one direction; a color conversion layer configured to convert light that has passed through the light guide film into light of a specific color; and an optical member disposed on the color conversion layer. The light sources include first light sources arranged on a first row of the printed circuit board, and second light sources arranged on a second row of the printed circuit board. The first light sources are spaced apart from each other by a predetermined distance, and the second light sources are spaced apart from each other by the predetermined distance.

Abstract: A lighting device irradiating light to different locations includes a light irradiation unit that generates light; an optical path adjustment unit that adjusts a path of the light radiated from the light irradiation unit to allow a road surface pattern to be formed at a predetermined location on a road surface around a vehicle; and a driving unit that adjusts the optical path adjustment unit to allow the road surface pattern to be formed at different locations on the road surface around the vehicle.

Abstract: A B7-H3 antibody or antigen-binding fragment thereof includes a heavy chain variable region including heavy chain complementarity determining regions (HCDRs) and a light chain variable region including light chain complementarity determining regions (LCDRs). The B7-H3 antibody has a predetermined complementarity determining region, thereby specifically binding to a B7-H3 antigen, and being internalized into cells, and being usable as an immune checkpoint inhibitor for various diseases.

Abstract: The present invention relates to a novel p62 ligand compound, a stereoisomer, hydrate, solvate or prodrug thereof, and a pharmaceutical or food composition for preventing or treating proteinopathies comprising the same as an active ingredient. The p62 ligand compound according to the present invention can be usefully used as a pharmaceutical composition for the prevention, amelioration or treatment of various proteinopathies by activating autophagy in cells and thus selectively eliminating in vivo proteins, organelles and aggregates.

Abstract: Disclosed is a lower folding device for forming dumplings. The lower folding device for forming dumplings according to the present invention comprises: a dumpling skin pressing unit which includes a plurality of dumpling skin folding units that are simultaneously operated, and which drives the plurality of dumpling skin folding units at a preset position; a cam rail unit for folding which is arranged adjacent to the dumpling skin pressing unit and is connected to the dumpling skin pressing unit to move the dumpling skin folding units; and a movement unit for folding which is connected to the dumpling skin pressing unit and moves the dumpling skin pressing unit relative to the cam rail unit for folding.

Abstract: An in-line dumpling molding system is disclosed. The in-line dumpling molding system according to the present invention comprises: a dumpling wrapper cutting device, which cuts a supplied dough sheet to form dumpling wrappers; a dumpling-molding lower folding device, which is disposed below the dumpling wrapper cutting device, on which the cut dumpling wrappers are loaded, and which presses and folds the dumpling wrappers onto which dumpling fillings have been supplied; and a sealing device, which is disposed above the dumpling-molding lower folding device, and presses and seals the folded dumpling wrappers.

Abstract: A railess variable seatback type rear seat includes: a linear movement device configured to convert a rotation of a motor into a linear movement; a sliding movement device configured to convert the linear movement into a sliding movement in which a seat cushion is pushed forward or backward; and a reclining angle change device configured to convert the sliding movement into a reclining movement, and to fold a seatback, which is connected to the seat cushion, forward or to recline the seatback backward.

Abstract: A display device includes: a first pixel electrode disposed in a first emission area, on a substrate; an insulating layer covering edges of the first pixel electrode; a first light-emitting layer disposed on the first pixel electrode and the insulating layer; a first common electrode disposed on the first light-emitting layer; banks disposed on the insulating layer and surrounding the first emission area; and a first organic pattern surrounding the first emission area, disposed on the banks, and including the same material as the first light-emitting layer. Side surfaces of each of the banks are spaced apart from side surfaces of the insulating layer.

Abstract: A display device includes a substrate, a light emitting element layer disposed on the substrate and including a plurality of light emitting areas each including a light emitting element that emits light, an encapsulation layer disposed on the light emitting element layer, and a light control layer disposed on the encapsulation layer, wherein the light control layer includes a light transmitting film that transmits the light and a light blocking film that blocks the light, and the light transmitting film includes, a first light transmitting portion overlapping the light blocking film in a thickness direction of the substrate, and a plurality of second light transmitting portions each surrounded by the light blocking film, and a thickness of the light blocking film is greater than a thickness of the first light transmitting portion.

Abstract: The present invention provides a positive electrode active material powder for lithium-ion rechargeable batteries, wherein the positive electrode active material comprises Li, M?, S and O, wherein M? consists of: Ni in a content x between 60.0 mol % and 95.0 mol %, relative to M? Co in a content y between 0.0 mol % and 25.0 mol %, relative to M?, Mn in a content z between 0.0 mol % and 25.0 mol %, relative to M?, W in a content a of 0.05 mol % or more, relative to M? D in a content b between 0.0 mol % and 2.0 mol %, relative to M?, wherein D comprises at least one element of the group consisting of: Al, B, Ba, Ca, Cr, F, Fe, Mg, Mo, Nb, Si, Sr, Ti, Y, V, Zn and Zr, and, wherein x, y, z, a, and b are measured by ICP, wherein x+y+z+a+b is 100.0 mol %, wherein the positive electrode active material comprises soluble sulfur in a content of 0.30 mol % or more, relative to M?.

Abstract: A host device, a storage device, and a method employ a vendor unique command (VUC) authentication system. The storage device includes a memory and a memory controller which includes a VUC authentication module and controls the memory. The VUC authentication module transmits first memory information about the memory to the host device, receives from the host device a one-time password generated by the first memory information, verifies the one-time password, and receives a vendor unique command from the host device when the one-time password is correct.

Abstract: This application relates to a composition for preventing, treating, and improving skeletal muscle atrophy, the composition including an organoselenium compound. The composition recovered the thickness of muscle fiber reduced by dexamethasone treatment. In addition, the treatment of mice in a muscle loss model showed that the composition had an effect of reducing damaged muscle and of restoring muscle mass. Therefore, it is expected that the composition can be effectively used for the treatment, prevention, or improvement of muscle atrophy.

Abstract: The present invention relates to a transport basket for defective spent nuclear fuel of a heavy water reactor and, more particularly, to a transport basket for defective spent nuclear fuel of a heavy water reactor that can reduce the burden of a personnel when handling spent nuclear fuel in a test facility by minimizing a storage space and maximizing a thickness such that only a predetermined amount of spent nuclear fuel for soundness evaluation in the test facility can be transported.

Abstract: Disclosed is an automated liquid-phase immunoassay apparatus used with a cuvette having a plurality of chambers containing a reagent necessary for detection of an analyte in a biological specimen. The apparatus includes a movable cuvette module equipped with the cuvette, an optical reading module for optical assaying of a material resulting from a reaction between the specimen and the reagent, and a dispenser module which is positioned on the cuvette module and which dispenses the specimen and the reagent to the plurality of chambers of the cuvette and washes the specimen and the reagent therefrom.

Abstract: A water purifier includes: a case including components; a cover mounted to the case to be opened and closed; a support frame mounted to the inside of the case and having at least one mounting part; a filter module detachably mounted to the case through the mounting part to filter and purify introduced raw water; a first flow path module including at least one flow path through which raw water flows and detachably mounted to the case between the case and the support frame to fix the filter module to the inside of the case; a second flow path module including at least one flow path through which purified water flows and which is connected to the components and the filter module, the second flow path module being detachably mounted to the case through the mounting part; and a faucet module mounted to the case to discharge purified water.

Abstract: A marker composition for predicting RCC prognosis, includes at least one gene selected from the group consisting of DUSP22, MAPK14, MAPKAPK3, STAT1, and VCP, discovered by the screening method of the present invention, or a protein encoded by the gene, and a pharmaceutical composition for treating RCC, includes a DUSP22 inhibitor of the present invention as an active ingredient.

Abstract: For methane activation, various sulfonation systems using SO3 or H2SO4 have been well studied, however, sulfur dioxide (SO2), a preliminary source of SO3 and H2SO4, has not been used successfully. Herein, we report a novel methane sulfonation method to produce methanesulfonic acid (MSA) utilizing sulfur dioxide by a free radical mechanism. In the presence of H2O2 as a radical initiator, the reaction of SO2 and O2 in trifluoroacetic acid (TFAOH) furnished trifluoroacetylsulfuric acid (TFAOSO3H), which served as the radical propagator to facilitate H-abstraction of methane at low temperatures. In typical reactions, sulfur dioxide was incorporated into MSA in 75% with high selectivity at 60° C.

Abstract: This application relates to a composition for preventing, treating, and improving skeletal muscle atrophy, the composition including an organoselenium compound. The composition recovered the thickness of muscle fiber reduced by dexamethasone treatment. In addition, the treatment of mice in a muscle loss model showed that the composition had an effect of reducing damaged muscle and of restoring muscle mass. Therefore, it is expected that the composition can be effectively used for the treatment, prevention, or improvement of muscle atrophy.

Abstract: A method for fabricating a light emitting element includes preparing a substrate, and forming a first semiconductor material layer, a light emitting material layer, a second semiconductor material layer and an electrode material layer on the substrate, forming semiconductor rods spaced apart from each other by etching the first semiconductor material layer, the light emitting material layer, the second semiconductor material layer and the electrode material layer in a direction perpendicular to an upper surface of the substrate, forming an insulating layer surrounding sides of the semiconductor rods through a sol-gel process by immersing the substrate, including the semiconductor rods, in a solution containing a precursor material, and forming light emitting elements by separating the semiconductor rods, including the insulating layer, from the substrate, and the light emitting elements have an external quantum efficiency of 20.2±0.6%.